Filing Details

Accession Number:
0001140361-16-066055
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-17 18:05:47
Reporting Period:
2016-05-09
Filing Date:
2016-05-17
Accepted Time:
2016-05-17 18:05:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1419582 Blue Sphere Corp. BLSP () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1232118 Lllp Partners Investment Lazarus 3200 Cherry Creek South Drive
Suite 670
Denver CO 80209
No No Yes No
1531960 B Justin Borus 3200 Cherry Creek South Drive
Suite 670
Denver CO 80209
No No Yes No
1531964 Lazarus Management Co Llc 3200 Cherry Creek South Drive
Suite 670
Denver CO 80209
No No Yes No
1539956 Lllp Fund Opportunities Israel Lazarus 3200 Cherry Creek Drive, Suite 670
Denver CO 80209
No No Yes No
1639750 Lllp Ii Fund Opportunities Israel Lazarus 3200 Cherry Creek South Drive
Suite 670
Denver CO 80209
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-09 50,000 $0.08 58,460,564 No 4 L Indirect See Footnotes
Common Stock Acquisiton 2016-05-10 5,000 $0.08 58,465,564 No 4 L Indirect See Footnotes
Common Stock Acquisiton 2016-05-11 20,000 $0.08 58,485,564 No 4 L Indirect See Footnotes
Common Stock Acquisiton 2016-05-12 51,000 $0.08 58,536,564 No 4 L Indirect See Footnotes
Common Stock Acquisiton 2016-05-16 85,000 $0.08 58,621,564 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 L Indirect See Footnotes
No 4 L Indirect See Footnotes
No 4 L Indirect See Footnotes
No 4 L Indirect See Footnotes
No 4 P Indirect See Footnotes
Footnotes
  1. Shares of common stock were purchased directly by Lazarus Israel Opportunities Fund II LLLP ("Lazarus Israel II").
  2. The Price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.078 to $0.0847, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  3. The Price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0827 to $0.0837, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  4. The Price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0811 to $0.0825, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  5. The Price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0804 to $0.0819, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  6. The Price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.075 to $0.079, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  7. This form is filed jointly by Lazarus Management Company LLC ("Lazarus Management"), Justin B. Borus, Lazarus Israel Opportunities Fund LLLP ("Lazarus Israel I"), Lazarus Israel II and Lazarus Investment Partners LLLP ("Lazarus Partners" and together with Lazarus Israel I and Lazarus Israel II, the "Funds"). The securities reported herein are owned directly by the Funds as follows: (i) Lazarus Israel I owns 41,682,641 shares of common stock and 12,500,000 warrants; (ii) Lazarus Israel II owns 8,138,447 shares of common stock and 2,727,273 warrants; and (iii) Lazarus Partners owns 8,800,476 shares of common stock and 2,272,728 warrants. Lazarus Management is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Lazarus Management.
  8. Each of Lazarus Management and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein. Each of the Funds expressly disclaims beneficial ownership of the shares held by the other Funds. The filing of this Form 4 shall not be construed as an admission that either Lazarus Management or Mr. Borus, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein.